Aquestive Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Aquestive Therapeutics, Inc. (AQST) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-11
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$2.14M.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $340.00K.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $685.00K, a 47.55% decline year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.72M, a 118.40% increase year-over-year.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$698.00K, a 413.00% decline from fiscal 2024.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $223.00K.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.29M.
- Aquestive Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.40M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$1.80M 10-Q · filed 2026-08-11 | -$1.11M derived: sum of 3 quarters · filed 2026-08-11 | $610.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $340.00K 10-Q · filed 2026-05-13 | $1.02M derived: sum of 2 quarters · filed 2026-05-13 | $2.75M derived: sum of 3 quarters · filed 2026-05-13 | $65.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $685.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.41M derived: sum of 2 quarters · filed 2026-03-04 | -$275.00K derived: sum of 3 quarters · filed 2026-08-11 | -$698.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$960.00K derived: sum of 2 quarters · filed 2026-08-11 | -$1.38M 10-Q · filed 2025-11-05 | -$77.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$3.10M 10-Q · filed 2026-08-11 | -$1.80M derived: sum of 3 quarters · filed 2026-08-11 | -$1.01M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$423.00K 10-Q · filed 2026-05-13 | $883.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.67M derived: sum of 3 quarters · filed 2026-05-13 | -$453.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.09M derived: sum of 2 quarters · filed 2026-03-04 | -$30.00K derived: sum of 3 quarters · filed 2026-03-04 | $223.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $788.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.34M derived: sum of 2 quarters · filed 2025-11-05 | -$1.08M 10-Q · filed 2025-11-05 | -$1.16M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$1.87M 10-Q · filed 2025-08-11 | -$1.94M derived: sum of 3 quarters · filed 2025-08-11 | -$1.35M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $253.00K 10-Q · filed 2025-05-12 | $180.00K derived: sum of 2 quarters · filed 2025-05-12 | $775.00K derived: sum of 3 quarters · filed 2025-05-12 | -$1.23M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $522.00K derived: sum of 2 quarters · filed 2025-03-05 | -$1.49M derived: sum of 3 quarters · filed 2025-03-05 | -$1.29M 10-K · filed 2025-03-05 |
| 2023-09-30 | $595.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$1.41M derived: sum of 2 quarters · filed 2024-11-04 | -$1.22M 10-Q · filed 2024-11-04 | -$505.00K derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.81M 10-Q · filed 2024-08-06 | -$1.10M derived: sum of 3 quarters · filed 2024-08-06 | -$765.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $195.00K 10-Q · filed 2024-05-07 | $907.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.24M derived: sum of 3 quarters · filed 2024-05-07 | -$1.43M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $712.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.05M derived: sum of 2 quarters · filed 2024-03-05 | -$1.63M derived: sum of 3 quarters · filed 2024-03-05 | -$1.40M 10-K · filed 2024-03-05 |
| 2022-09-30 | $335.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$2.34M derived: sum of 2 quarters · filed 2023-11-06 | -$2.11M 10-Q · filed 2023-11-06 | -$1.58M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | -$2.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$2.45M 10-Q · filed 2023-08-07 | -$1.91M derived: sum of 3 quarters · filed 2023-08-07 | -$1.17M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $230.00K 10-Q · filed 2023-05-02 | $765.00K derived: sum of 2 quarters · filed 2023-05-02 | $1.50M derived: sum of 3 quarters · filed 2023-05-02 | -$1.56M derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.27M derived: sum of 2 quarters · filed 2023-03-31 | -$1.79M derived: sum of 3 quarters · filed 2023-03-31 | -$1.26M 10-K · filed 2023-03-31 |
| 2021-09-30 | $739.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$2.33M derived: sum of 2 quarters · filed 2022-11-01 | -$1.79M 10-Q · filed 2022-11-01 | -$941.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | -$3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$2.53M 10-Q · filed 2022-08-02 | -$1.68M derived: sum of 3 quarters · filed 2022-08-02 | -$1.00M derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $535.00K 10-Q · filed 2022-05-04 | $1.39M derived: sum of 2 quarters · filed 2022-05-04 | $2.06M derived: sum of 3 quarters · filed 2022-05-04 | $8.54M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $852.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.53M derived: sum of 2 quarters · filed 2022-03-08 | $8.01M derived: sum of 3 quarters · filed 2022-03-08 | $7.95M 10-K · filed 2022-03-08 |
| 2020-09-30 | $675.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $7.15M derived: sum of 2 quarters · filed 2021-11-02 | $7.10M 10-Q · filed 2021-11-02 | $7.44M derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $6.43M 10-Q · filed 2021-08-03 | $6.76M derived: sum of 3 quarters · filed 2021-08-03 | $7.38M derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | -$53.00K 10-Q · filed 2021-05-04 | $284.00K derived: sum of 2 quarters · filed 2021-05-04 | $897.00K derived: sum of 3 quarters · filed 2021-05-04 | -$402.00K derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $950.00K derived: sum of 2 quarters · filed 2021-03-09 | -$349.00K derived: sum of 3 quarters · filed 2021-03-09 | $1.37M 10-K · filed 2021-03-09 |
| 2019-09-30 | $613.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$686.00K derived: sum of 2 quarters · filed 2020-11-04 | $1.03M 10-Q · filed 2020-11-04 | $1.28M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $416.00K 10-Q · filed 2020-08-04 | $667.00K derived: sum of 3 quarters · filed 2020-08-04 | $1.38M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $1.72M 10-Q · filed 2020-05-05 | $1.97M derived: sum of 2 quarters · filed 2020-05-05 | $2.68M derived: sum of 3 quarters · filed 2020-05-05 | |
| 2018-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $961.00K derived: sum of 2 quarters · filed 2020-03-11 | $1.14M 10-K · filed 2020-03-11 | |
| 2018-09-30 | $710.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $889.00K 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $179.00K 10-Q · filed 2018-09-04 | |||
| 2017-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$78.00K 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | -$33.00K 10-Q · filed 2018-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |